Current Enterprise Value (EV)
Current share price (P) | $114.23 |
No. shares of common stock outstanding | 1,734,455,213 |
US$ in millions | |
Common equity (market value)1 | 198,127) |
Add: Preferred shares, one dollar par value, none issued (per books) | —) |
Add: Noncontrolling interests in subsidiaries (per books) | 224) |
Total equity | 198,351) |
Add: Short-term borrowings (per books) | —) |
Add: Current portion of long-term debt (per books) | 1,080) |
Add: Long-term debt, excluding current portion (per books) | 13,599) |
Total equity and debt | 213,030) |
Less: Cash and cash equivalents | 6,896) |
Less: Investments, primarily bank time deposits and U.S. treasury bills | 383) |
Enterprise value (EV) | 205,751) |
Based on: 10-K (reporting date: 2023-12-31).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 114.23 × 1,734,455,213
Historical Enterprise Value (EV)
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of Abbott Laboratories Annual Report.
3 2023 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 114.01 × 1,735,184,289
Item | Description | The company |
---|---|---|
EV | Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. | Abbott Laboratories EV decreased from 2021 to 2022 but then increased from 2022 to 2023 not reaching 2021 level. |